Quipt Home Medical Corp T.QIPT

Alternate Symbol(s): QIPT

Healthcare

Quipt Home Medical Corp. is a home medical equipment provider. The Company specializes in improving the home management of chronic illness through the application of telehealth systems and automated distribution. It provides in-home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States. It offers nebulizers, oxygen concentrators, continuous positive airway pressure (CPAP) and Bilevel Positive Airway Pressure (BiPAP) units; traditional and non-traditional medical respiratory equipment and services, and non-invasive ventilation equipment, supplies, and services. The Company's product offerings include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility, and other chronic health conditions. Its products and services consist of sleep apnea and pap treatment, home ventilation, daily and ambulatory aides, and respiratory equipment rental.

TSX:QIPT - Post by User

Quipt Home Medical Corp > Why Richie Capital dumped VMD-Quipt down same path?

<< Previous

Bullboard Posts

Next >>

Post by besttobeon Feb 04, 2022 7:13am

219 Views

Post# 34396437

Why Richie Capital dumped VMD-Quipt down same path?

Here is what Richie Capital Group had to say about Viemed Healthcare compensation plan....

"We exited our position in Viemed Healthcare (VMD)

Another concern was their handling of executive compensation. From the beginning, I was frustrated by management’s insistence on adding back options grants to their reported Adjusted EBITDA numbers. Option grants are a real expense and should be treated as such, and so we made adjustments to our own internal numbers. Furthermore, I observed that their options compensation for executives was much higher than should be for such a small company. Management continued to grant options despite the company’s underperformance during the pandemic. I realized that as the stock continued to decline and those options lost value, management would be forced to issue even more options (diluting existing shareholders) or risk losing executives seeking greener pastures.